Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896429864> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2896429864 endingPage "S91" @default.
- W2896429864 startingPage "S90" @default.
- W2896429864 abstract "Radiation therapy-associated cardiac toxicity in patients with NSCLC arises sooner and is of greater clinical significance than historically appreciated. Recent studies have been limited by inconsistent definitions and small size. This study reports major cardiac events after RT in a large cohort of patients with NSCLC using comprehensive, validated cardiac toxicity criteria and dose-volume data. Retrospective study of 748 patients with Stage II (9%) to III (91%) NSCLC treated with 3D-conformal (77%) or intensity-modulated (22%) RT (median dose, 64 Gy) and chemotherapy (61%), chemotherapy and surgery (33%), or RT alone (4%) between 1998–2014 at one institution. Hearts were re-contoured per cardiac atlas definitions. Patients without baseline coronary heart disease (CHD) or CHD risk equivalent were stratified by Framingham risk. Primary endpoint was major cardiac events, defined as any grade ≥3 Common Terminology Criteria for Adverse Events (CTCAE, v4.03) or Major Adverse Cardiac Events (MACE). Estimates of Kaplan-Meier overall survival (OS) and cumulative incidence of cardiac events (non-cardiac death as a competing risk) were calculated. Fine and Gray and Cox regressions were performed. Median follow up from RT was 1.9 years. Median mean heart dose was 12.3 Gy. Two-year OS stratified by low, moderate, or high Framingham risk group or known CHD was 62.7%, 56.0%, 47.0%, and 46.8%, respectively (P=.001). Median time to first major cardiac event was 10.4 months; cumulative incidence at 1, 2, and 5-years was 18.2%, 23.5%, and 32.4%, respectively. Two-year cumulative incidence of major cardiac events (conduction, 12.0%; heart failure, 5.7%; MACE, 4.8%; pericardial [all], 4.7%; pericardial [effusion, cytology benign], 1.8%; coronary/ischemic, 2.5%; valvular, 1.1%; and cardiopulmonary/other, 5.4%) was increased in patients with vs without baseline CHD (31.2% vs 18.9%; P<.0001) and those with mean heart dose >12 Gy vs ≤12 Gy (26.7% vs 19.3%; P=.009), respectively. On multivariable analysis (MVA), baseline CHD (hazard ratio [HR] 1.75, 95% CI 1.35–2.28; P<.0001) and mean heart dose (HR 1.09/5 Gy, 95% CI 1.02–1.16; P=.013) were significantly associated with major cardiac events. On MVA accounting for baseline CHD and known lung cancer prognostic factors, major cardiac events were significantly associated with decreased OS (HR 2.91, 95% CI 2.39–3.55; P<.0001), while mean heart dose was not (HR 1.04/5 Gy, 95% CI 0.99–1.09; P=.107). In this large cohort of patients with NSCLC, major cardiac events were common, occurred sooner than previously reported, and were associated with baseline CHD and heart dose. These results build upon recent reports, support efforts to minimize heart irradiation, and highlight the importance of pre-treatment cardiac risk assessment and development of risk mitigation strategies for high risk patients." @default.
- W2896429864 created "2018-10-26" @default.
- W2896429864 creator A5001452511 @default.
- W2896429864 creator A5001986733 @default.
- W2896429864 creator A5039369605 @default.
- W2896429864 creator A5051633243 @default.
- W2896429864 creator A5057173854 @default.
- W2896429864 creator A5064724289 @default.
- W2896429864 creator A5065415217 @default.
- W2896429864 creator A5067347913 @default.
- W2896429864 creator A5074739519 @default.
- W2896429864 creator A5075890039 @default.
- W2896429864 creator A5084951029 @default.
- W2896429864 creator A5087533071 @default.
- W2896429864 date "2018-11-01" @default.
- W2896429864 modified "2023-10-16" @default.
- W2896429864 title "Cardiac Events after Radiation Therapy (RT) for Stage II-III Non-Small Cell Lung Cancer (NSCLC): Analysis of 748 Patients" @default.
- W2896429864 doi "https://doi.org/10.1016/j.ijrobp.2018.06.236" @default.
- W2896429864 hasPublicationYear "2018" @default.
- W2896429864 type Work @default.
- W2896429864 sameAs 2896429864 @default.
- W2896429864 citedByCount "1" @default.
- W2896429864 countsByYear W28964298642020 @default.
- W2896429864 crossrefType "journal-article" @default.
- W2896429864 hasAuthorship W2896429864A5001452511 @default.
- W2896429864 hasAuthorship W2896429864A5001986733 @default.
- W2896429864 hasAuthorship W2896429864A5039369605 @default.
- W2896429864 hasAuthorship W2896429864A5051633243 @default.
- W2896429864 hasAuthorship W2896429864A5057173854 @default.
- W2896429864 hasAuthorship W2896429864A5064724289 @default.
- W2896429864 hasAuthorship W2896429864A5065415217 @default.
- W2896429864 hasAuthorship W2896429864A5067347913 @default.
- W2896429864 hasAuthorship W2896429864A5074739519 @default.
- W2896429864 hasAuthorship W2896429864A5075890039 @default.
- W2896429864 hasAuthorship W2896429864A5084951029 @default.
- W2896429864 hasAuthorship W2896429864A5087533071 @default.
- W2896429864 hasConcept C11783203 @default.
- W2896429864 hasConcept C126322002 @default.
- W2896429864 hasConcept C143998085 @default.
- W2896429864 hasConcept C151032500 @default.
- W2896429864 hasConcept C164705383 @default.
- W2896429864 hasConcept C167135981 @default.
- W2896429864 hasConcept C203092338 @default.
- W2896429864 hasConcept C207103383 @default.
- W2896429864 hasConcept C2776256026 @default.
- W2896429864 hasConcept C2777793932 @default.
- W2896429864 hasConcept C2779134260 @default.
- W2896429864 hasConcept C2780400711 @default.
- W2896429864 hasConcept C2780739214 @default.
- W2896429864 hasConcept C44249647 @default.
- W2896429864 hasConcept C500558357 @default.
- W2896429864 hasConcept C50382708 @default.
- W2896429864 hasConcept C509974204 @default.
- W2896429864 hasConcept C535046627 @default.
- W2896429864 hasConcept C71924100 @default.
- W2896429864 hasConcept C72563966 @default.
- W2896429864 hasConcept C88879693 @default.
- W2896429864 hasConceptScore W2896429864C11783203 @default.
- W2896429864 hasConceptScore W2896429864C126322002 @default.
- W2896429864 hasConceptScore W2896429864C143998085 @default.
- W2896429864 hasConceptScore W2896429864C151032500 @default.
- W2896429864 hasConceptScore W2896429864C164705383 @default.
- W2896429864 hasConceptScore W2896429864C167135981 @default.
- W2896429864 hasConceptScore W2896429864C203092338 @default.
- W2896429864 hasConceptScore W2896429864C207103383 @default.
- W2896429864 hasConceptScore W2896429864C2776256026 @default.
- W2896429864 hasConceptScore W2896429864C2777793932 @default.
- W2896429864 hasConceptScore W2896429864C2779134260 @default.
- W2896429864 hasConceptScore W2896429864C2780400711 @default.
- W2896429864 hasConceptScore W2896429864C2780739214 @default.
- W2896429864 hasConceptScore W2896429864C44249647 @default.
- W2896429864 hasConceptScore W2896429864C500558357 @default.
- W2896429864 hasConceptScore W2896429864C50382708 @default.
- W2896429864 hasConceptScore W2896429864C509974204 @default.
- W2896429864 hasConceptScore W2896429864C535046627 @default.
- W2896429864 hasConceptScore W2896429864C71924100 @default.
- W2896429864 hasConceptScore W2896429864C72563966 @default.
- W2896429864 hasConceptScore W2896429864C88879693 @default.
- W2896429864 hasIssue "3" @default.
- W2896429864 hasLocation W28964298641 @default.
- W2896429864 hasOpenAccess W2896429864 @default.
- W2896429864 hasPrimaryLocation W28964298641 @default.
- W2896429864 hasRelatedWork W2213857236 @default.
- W2896429864 hasRelatedWork W2528919078 @default.
- W2896429864 hasRelatedWork W2590437451 @default.
- W2896429864 hasRelatedWork W2906013683 @default.
- W2896429864 hasRelatedWork W3146182361 @default.
- W2896429864 hasRelatedWork W3189303933 @default.
- W2896429864 hasRelatedWork W4301393886 @default.
- W2896429864 hasRelatedWork W4304784072 @default.
- W2896429864 hasRelatedWork W4311192294 @default.
- W2896429864 hasRelatedWork W4323364654 @default.
- W2896429864 hasVolume "102" @default.
- W2896429864 isParatext "false" @default.
- W2896429864 isRetracted "false" @default.
- W2896429864 magId "2896429864" @default.
- W2896429864 workType "article" @default.